435 results found

« Return to search form

Download results as CSV or XML
Company Parent Location Subsidy Source Year Subsidy Valuesort icon Loan/Bailout Value Type of Subsidy
ACAMBIS INC Sanofi United States federal 2004 $67,000,000 federal grant
Novozymes Blair, Inc. Novo A/S United States federal 2010 $28,401,000 federal allocated tax credit
AMYRIS, INC. Amyris United States federal 2010 $24,341,409 federal grant
XOMA (US) LLC Xoma Corp. United States federal 2005 $15,000,000 federal grant
NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH, Novartis United States federal 2017 $12,060,156 federal grant
CHIRON CORPORATION Novartis United States federal 2000 $11,094,599 federal grant
CHIRON CORPORATION Novartis United States federal 2004 $10,427,728 federal grant
CELGENE CORPORATION Celgene United States federal 2010 $10,061,240 federal grant
SHIRE BIOLOGICS INC Takeda Pharmaceutical United States federal 2004 $9,500,092 federal grant
ACAMBIS INC Sanofi United States federal 2005 $9,284,386 federal grant
ACAMBIS INC Sanofi United States federal 2003 $9,241,818 federal grant
CHIMERIX INC Chimerix United States federal 2005 $8,477,202 federal grant
CHIMERIX INC Chimerix United States federal 2004 $7,492,027 federal grant
CELGENE CORPORATION Celgene United States federal 2012 $7,489,743 federal grant
WYETH PHARMACEUTICALS INC Pfizer United States federal 2003 $7,271,925 federal grant
AMYRIS, INC. Amyris United States federal 2016 $7,000,000 federal grant
AMYRIS, INC. Amyris United States federal 2018 $7,000,000 federal grant
AMYRIS, INC. Amyris United States federal 2019 $7,000,000 federal grant
CHIRON CORPORATION Novartis United States federal 2005 $6,884,362 federal grant
AMYRIS, INC. Amyris United States federal 2018 $6,825,720 federal grant
WYETH PHARMACEUTICALS INC Pfizer United States federal 2005 $6,364,931 federal grant
WYETH Pfizer United States federal 2005 $5,636,276 federal grant
TAKEDA VACCINES, INC. Takeda Pharmaceutical United States federal 2018 $5,385,144 federal grant
WYETH PHARMACEUTICALS INC Pfizer United States federal 2005 $4,934,072 federal grant
AVENTIS PASTEUR, INC Sanofi United States federal 2004 $4,923,670 federal grant
CHIRON CORPORATION Novartis United States federal 2002 $4,920,585 federal grant
MEDIMMUNE, LLC AstraZeneca United States federal 2018 $4,893,180 federal grant
MEDIMMUNE, LLC AstraZeneca United States federal 2017 $4,864,964 federal grant
NOVOZYMES, INC Novo A/S United States federal 2008 $4,694,082 federal grant
NOVOZYMES, INC Novo A/S United States federal 2008 $4,694,082 federal grant
REGENERON PHARMACEUTICALS INC Regeneron Pharmaceuticals United States federal 2007 $4,614,400 federal grant
NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH, Novartis United States federal 2014 $4,327,868 federal grant
ETHICON, INC Johnson & Johnson United States federal 2009 $4,260,809 federal grant
GlaxoSmithKline GlaxoSmithKline United States federal 2012 $4,011,709 federal grant
NOVARTIS VACCINES DIAGNOSTICS, Novartis United States federal 2012 $3,864,927 federal grant
CHIRON CORPORATION Novartis United States federal 2002 $3,840,693 federal grant
PFIZER INC. Pfizer United States federal 2014 $3,823,709 federal grant
AMERICAN HOME PRODUCTS CORPORATION Pfizer United States federal 2000 $3,773,578 federal grant
CELGENE CORPORATION Celgene United States federal 2011 $3,687,247 federal grant
AMYRIS BIOTECHNOLOGIES, INC Amyris United States federal 2012 $3,595,518 federal grant
AMERICAN HOME PRODUCTS CORPORATION Pfizer United States federal 2004 $3,582,393 federal grant
PROGENICS PHARMACEUTICALS, INC Progenics Pharmaceuticals United States federal 2004 $3,351,512 federal grant
NOVOZYMES, INC Novo A/S United States federal 2009 $3,289,888 federal grant
AMERICAN HOME PRODUCTS CORPORATION Pfizer United States federal 2001 $3,247,250 federal grant
CELGENE CORPORATION Celgene United States federal 2009 $3,170,533 federal grant
AVENTIS PASTEUR, INC Sanofi United States federal 2003 $3,121,883 federal grant
PROGENICS PHARMACEUTICALS, INC Progenics Pharmaceuticals United States federal 2003 $3,054,013 federal grant
PROGENICS PHARMACEUTICALS, INC Progenics Pharmaceuticals United States federal 2005 $3,000,072 federal grant
CHIRON CORPORATION Novartis United States federal 2003 $2,984,358 federal grant
CHIRON CORPORATION Novartis United States federal 2003 $2,984,358 federal grant
WYETH PHARMACEUTICALS INC Pfizer United States federal 2002 $2,968,632 federal grant
PFIZER INC. Pfizer United States federal 2014 $2,784,665 federal grant
AstraZeneca Pharmaceuticals LP AstraZeneca United States federal 2012 $2,713,491 federal grant
NOVARTIS VACCINES AND DIAGNOSTICS, INC Novartis United States federal 2014 $2,713,057 federal grant
NOVAVAX, INC Novavax Inc. United States federal 2003 $2,695,203 federal grant
GENOCEA BIOSCIENCES INC Genocea Biosciences United States federal 2009 $2,685,993 federal grant
ACORDA THERAPEUTICS, INC Acorda Therapeutics United States federal 2013 $2,675,008 federal grant
NOVOZYMES, INC. Novo A/S United States federal 2013 $2,500,000 federal grant
NOVOZYMES, INC. Novo A/S United States federal 2018 $2,500,000 federal grant
NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH, Novartis United States federal 2015 $2,473,302 federal grant
SANOFI PASTEUR VAXDESIGN CORPORATION Sanofi United States federal 2014 $2,433,738 federal grant
CHIRON CORPORATION Novartis United States federal 2004 $2,407,540 federal grant
MEDIMMUNE, LLC AstraZeneca United States federal 2018 $2,383,754 federal grant
SANOFI US SERVICES INC. Sanofi United States federal 2018 $2,382,409 federal grant
AVENTIS PASTEUR, INC Sanofi United States federal 2004 $2,362,639 federal grant
CHIRON CORPORATION Novartis United States federal 2001 $2,359,223 federal grant
STRATATECH CORPORATION Mallinckrodt United States federal 2016 $2,357,660 federal grant
CHIRON CORPORATION Novartis United States federal 2003 $2,306,242 federal grant
MORPHOTEK INC Eisai United States federal 2007 $2,265,000 federal grant
CHIRON CORPORATION Novartis United States federal 2004 $2,255,121 federal grant
PTC THERAPEUTICS, INC PTC Therapeutics United States federal 2006 $2,219,415 federal grant
PROTEIN SCIENCES CORPORATION Sanofi United States federal 2003 $2,213,730 federal grant
NOVOZYMES, INC Novo A/S United States federal 2010 $2,156,352 federal grant
PROGENICS PHARMACEUTICALS, INC Progenics Pharmaceuticals United States federal 2001 $2,090,481 federal grant
CHIRON CORPORATION Novartis United States federal 2004 $2,040,362 federal grant
CHIMERIX INC Chimerix United States federal 2003 $2,005,821 federal grant
EASEL BIOTECHNOLOGIES Celgene United States federal 2015 $2,000,000 federal grant
EASEL BIOTECHNOLOGIES Celgene United States federal 2018 $2,000,000 federal grant
PROGENICS PHARMACEUTICALS, INC Progenics Pharmaceuticals United States federal 2000 $1,974,283 federal grant
FLEXION THERAPEUTICS, INC. Flexion Therapeutics United States federal 2013 $1,970,121 federal grant
SANOFI PASTEUR VAXDESIGN CORPORATION Sanofi United States federal 2015 $1,923,532 federal grant
AMERICAN HOME PRODUCTS CORPORATION Pfizer United States federal 2002 $1,894,602 federal grant
CHIRON CORPORATION Novartis United States federal 2002 $1,894,091 federal grant
MORPHOTEK INC Eisai United States federal 2008 $1,776,380 federal grant
NOVARTIS VACCINES AND DIAGNOSTICS, INC Novartis United States federal 2015 $1,717,293 federal grant
SANOFI PASTEUR VAXDESIGN CORPORATION Sanofi United States federal 2018 $1,627,483 federal grant
AMERICAN HOME PRODUCTS CORPORATION Pfizer United States federal 2003 $1,616,058 federal grant
IMMUNOMEDICS, INC. Immunomedics United States federal 2013 $1,615,021 federal grant
REGENERON PHARMACEUTICALS INC Regeneron Pharmaceuticals United States federal 2010 $1,595,238 federal grant
IBIS BIOSCIENCES INC Abbott Laboratories United States federal 2009 $1,591,169 federal grant
ANIMAS CORPORATION Johnson & Johnson United States federal 2001 $1,589,000 federal grant
NOVOZYMES NORTH AMERICA, INC. Novo A/S United States federal 2017 $1,568,670 federal grant
NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH, Novartis United States federal 2018 $1,546,698 federal grant
OPTIMER PHARMACEUTICALS INC Merck United States federal 2005 $1,521,978 federal grant
REGENERON PHARMACEUTICALS INC Regeneron Pharmaceuticals United States federal 2006 $1,521,300 federal grant
SANOFI PASTEUR VAXDESIGN CORPORATION Sanofi United States federal 2017 $1,500,013 federal grant
PROTEIN SCIENCES CORPORATION Sanofi United States federal 2001 $1,478,925 federal grant
EMBREX, INC. Pfizer United States federal 2005 $1,403,707 federal grant
CELGENE CORPORATION Celgene United States federal 2011 $1,400,000 federal grant
CHEMOCENTRYX, INC. ChemoCentryx United States federal 2000 $1,372,600 federal grant
ALEXION ANTIBODY TECHNOLOGIES Alexion Pharmaceuticals United States federal 2005 $1,356,000 federal grant
Download results as CSV or XML